Bright Minds Biosciences Inc (DRUG) financial metrics
Select a metric to see reported values, dates and history. Availability depends on the company’s FMP coverage; missing values are not filled in.
Market Data
Growth
- DRUG Revenue Growth
- DRUG Net Income Growth
- DRUG EPS Growth
- DRUG Operating Income Growth
- DRUG Gross Profit Growth
- DRUG R&D Expense Growth
- DRUG Free Cash Flow Growth
- DRUG Operating Cash Flow Growth
- DRUG EBITDA Growth
- DRUG Debt Growth
- DRUG Asset Growth
- DRUG SG&A Expense Growth
- DRUG Book Value/Share Growth
- DRUG Dividends/Share Growth
Valuation
Profitability
Financial Health
Income Statement
- DRUG Revenue
- DRUG Cost of Revenue
- DRUG Gross Profit
- DRUG Gross Margin
- DRUG R&D Expenses
- DRUG SG&A Expenses
- DRUG Operating Expenses
- DRUG Operating Income
- DRUG Operating Margin
- DRUG Interest Expense
- DRUG Income Before Tax
- DRUG Income Tax Expense
- DRUG Net Income
- DRUG Net Margin
- DRUG EBITDA
- DRUG EPS
- DRUG EPS Diluted
- DRUG Shares Out (Diluted)
- DRUG Shares Out (Basic)
- DRUG Total Costs & Expenses
- DRUG Interest Income
- DRUG EBITDA Margin
- DRUG Pre-Tax Margin
- DRUG Other Income/Expenses (Net)
Balance Sheet
- DRUG Cash & Equivalents
- DRUG Total Current Assets
- DRUG Total Assets
- DRUG Total Current Liabilities
- DRUG Total Liabilities
- DRUG Stockholders Equity
- DRUG Short-Term Investments
- DRUG Net Receivables
- DRUG Inventory
- DRUG Property Plant Equipment Net
- DRUG Goodwill & Intangibles
- DRUG Long-Term Investments
- DRUG Accounts Payable
- DRUG Short-Term Debt
- DRUG Long-Term Debt
- DRUG Total Debt
- DRUG Net Debt
- DRUG Retained Earnings
- DRUG Cash & Short-Term Investments
- DRUG Goodwill
- DRUG Intangible Assets
- DRUG Other Current Assets
- DRUG Total Non-Current Assets
- DRUG Total Non-Current Liabilities
- DRUG Deferred Revenue
- DRUG Common Stock
- DRUG Accumulated OCI
- DRUG Total Investments
- DRUG Capital Lease Obligations
Cash Flow
- DRUG Operating Cash Flow
- DRUG Operating Cash Flow (Statement)
- DRUG Capital Expenditure
- DRUG Free Cash Flow
- DRUG Stock-Based Compensation
- DRUG Net Change in Cash
- DRUG Depreciation & Amortization
- DRUG Change in Working Capital
- DRUG Investing Cash Flow
- DRUG Financing Cash Flow
- DRUG Stock Repurchases
- DRUG Debt Repayment
- DRUG Dividends Paid
- DRUG Net Acquisitions
- DRUG Purchases of Investments
- DRUG Sales/Maturities of Investments
- DRUG Common Stock Issued
- DRUG Forex Effect on Cash
- DRUG Operating CF Margin
- DRUG Free CF Margin
- DRUG Cash Conversion Ratio
